Purpose The purpose of this study was to evaluate the effects of epineurotomy on the post-surgical median nerve volume and clinical outcomes in carpal tunnel syndrome (CTS) patients with a prominent nerve narrowing. Methods This was a prospective, randomised, double-blind controlled trial. Patients (n050) were randomised (1:1) to open-field surgical carpal tunnel release followed by a longitudinal epineurotomy of the nerve (test), or to open-field release without epineurotomy (control). Results The nerve volume was slightly larger in the test group 90 days post-surgery (by 10.5 %, p00.157) but not 180 days post-surgery. No relevant electropyhsiological or clinical difference between groups and no effect of the nerve volume was observed. The subjective pain reduction was slightly more prominent in the control group at 180 days. Larger post-surgical nerve volume was associated with lower pain, but only in the control group. Conclusions Even in selected CTS patients, longitudinal epineurotomy confers no benefit regarding the nerve volume or clinical outcomes over a simple carpal tunnel release.
Introduction
The carpal tunnel syndrome (CTS) is the most common canalicular syndrome in humans and compressive neuropathy of the median nerve within the tunnel is a common cause of hand disability [1, 2] . Surgical release of the tunnel reduces pressure, allows for restoration of the intraneuronal blood flow and physiological function, and is treatment of choice in persistent/progressive cases [3] . Open-field and endoscopic techniques do not seem to differ in efficacy and patient satisfaction [4] . However, the open-field approach allows for manipulations that could additionally improve the outcomes. Long-lasting nerve compression may result in fibrotic changes generating further mechanical pressure and narrowing of the nerve. In such cases, longitudinal epineurotomy of the nerve as described by Foulkes et al. [5] and Leinberry et al. [6] has been suggested [7, 8] as an option that could convey a greater pressure release, a more prominent nerve volume recovery and better outcomes.
Consequently, the method has been widely used [9] . However, randomised controlled trials failed to demonstrate additional benefits of epineurotomy on the electrophysiological and clinical outcomes [5, 6, 10] . A potential limitation of these trials [5, 6, 10] was that they were not restricted to patients with a clear-cut nerve fibrosis/narrowing. We aimed to evaluate the concept underlying the recommendation about the use of epineurotomy. Our trial assessed the effects of epineurotomy on the post-surgical nerve volume and related it to the electrophysiological and clinical outcomes specifically in patients with a prominent nerve narrowing.
Patients and methods

General design and ethics
This single-centre, prospective, randomised, doubleblind controlled trial was approved by the local Ethics Committee. Patients were randomised (1:1) to undergo open-field release of the carpal tunnel followed by a longitudinal epineurotomy of the median nerve [5, 6] (test), or the open-field release without epineurotomy (control), and were assessed 90 and 180 days post-surgery.
Eligible patients
Included were consecutive adults (≥18 years of age) with symptoms of CTS that could not be managed by conservative means meeting the following criteria: (a) verified CTS [clinical signs/symptoms, electromyoneurographical (EMNG) evaluation (distal sensory latency >3.5 ms and/or distal motor latency >4.5 ms)] [11, 12] ; (b) informed consent; and (c) intrasurgically verified narrowing of the median nerve within the tunnel. This was performed by the operating surgeon based on the appearance of the nerve in the form of an hourglass. Pregnant women and patients with a previous surgery of the affected hand were not included.
Randomisation and blinding
A randomisation list (permutated block, four per block) was kept in a sealed envelope without access by the investigators included in any phase of the trial. Since the inclusion was finally verified intra-surgically, the person in charge was present in the operating room and disclosed the assigned treatment. Further measures ascertained double-blinding: (a) patients were blinded to the treatment, (b) all operations were performed by the same surgeon, whereas the postsurgical clinical evaluations were performed by independent investigators, (c) EMNG evaluations were performed by the same blinded neurologist, (d) radiological evaluations were performed by the same blinded radiologist, and (e) data analysis was blinded.
Study flow and patient evaluations
Before the surgery, patients underwent EMNG (15-30 days before), radiological and clinical evaluations (one to three days before), and the same assessments were repeated 90 and 180 days after the surgery (±7 days) (Fig. 1) .
Magnetic resonance imaging (MRI) was used to estimate the median nerve volume within the carpal tunnel based on measurements performed in T2 and T2* WFS slices (Hitachi Airis-II 0.3T apparatus) with patients lying in the Fig. 1 Study and patient flow. EMNG electromyeloneurography, MRI magnetic resonance imaging, DSL distal sensory latency, DML distal motor latency, VAS visual analogue scale prone position, the hand extended overhead and placed in a neutral position within a coil designed for the wrist [13, 14] . Proximal and distal borders of the carpal tunnel were determined in the coronal plain [13] , and four to nine axial sections, 3-mm wide, were performed (section width, W), depending on the carpal tunnel length. The image was enlarged and the median nerve was outlined to obtain the area of the axial section (mm 2 ). Each section was outlined three times and the mean value for each section was obtained (mean axial area, MAA, mm 2 ). The volume of each axial nerve section was determined from the section area and section width (MAA x W) and their summation yielded the total estimated nerve volume within the carpal tunnel. Since the number of individual axial sections varied, the mean value (total nerve volume/number of axial sections) was used for treatment comparisons.
Orthodromic EMNG (MEB 2000 apparatus, Nihon Kohden) of the median nerve was performed in order to estimate distal motor and distal sensory latency (DML, DSL, respectively) [15] . Motor and sensory conduction velocity and myography of the thenar eminence were also performed in order to verify the diagnosis.
Clinical assessments were performed at least five days after the last analgesic dose and evaluated [16] : (a) spontaneous pain (10-point visual analogue scale [VAS], 00no pain to 100excruciating pain), (b) subjective hand functionality (10-point VAS, 00no dysfunction to 100completely dysfunctional), (c) thenar hypotrophy, (d) range of movements and provocations tests, and (e) grip strength (kg) (dynamometer, Collin-Rudolf instruments).
Surgical procedures and post-surgical care
Operations were performed by a standardised technique [16] under pneumatic tourniquet control and general anaesthesia. A "square-root"-shaped skin incision was made and the carpal ligament was dissected. The test procedure included a longitudinal incision of the ulnar palmar epineurium of the median nerve extending throughout the carpal tunnel [5, 6] . The wound was irrigated with sterile saline and only the skin was sutured (Nylon 4-0). The wrist was immobilised in dorsal flexion (five to ten degrees) for ten days. After removal of the immobilisation and sutures, all patients underwent the same rehabilitation protocol (cryotherapy, exercises of hand mobility, grip strength and limb circulation). The test procedure (from placement to removal of the tourniquet) lasted seven to 25 minutes and the control procedure lasted seven to 12 minutes.
Outcomes
Primary outcome was post-surgical median nerve volume. The four secondary outcomes referred to electrophysiological and objective and subjective clinical status: (a) proportion of patients with normal (≤4.5 milliseconds) or improved DML (reduction of ≥0.5 milliseconds vs. the presurgical value or any measurable value in patients with a motor block before the surgery), (b) proportion of patients with normal (≤3.5 milliseconds) or improved DSL (as for DML), (c) grip strength, (d) VAS score for pain. Complications were also recorded.
Sample size and power considerations
Sample size was determined with respect to the primary outcome. We defined a difference of 25 % in post-surgical nerve volume as potentially relevant. With two repeated measures and one two-level between factor (treatment groups), sample size of 23 patients per group yields 80 % power at a two-sided 0.05 alpha level to detect such a difference, assuming first-order autoregressive covariance structure, correlation between measurements on the same subject of 0.5 and relative standard deviation of a single observation of 35 % [17] . Consequently, 25 subjects per group were included.
Data analysis
Not all patients underwent all of the planned assessments considering the defined outcomes (Fig. 1 ). Since the intention was to test for inequality, primary analysis was based on the intent-to-treat principle (ITT) and included all patients with the respective assessment performed at least before the surgery with last observation carried forward (ITT-LOCF). The analysis was also performed considering patients who underwent the assessments at post-surgical visits per protocol (PP-as measured). Data were analysed by fitting linear or generalised linear mixed models. We used SAS 9.2 for Windows (SAS Inc., Cary, NC).
Results
Apart from a higher proportion of men in the epineurotomy (test) than in the non-epineurotomy (control) group, before the surgery the groups were fairly comparable regarding patient characteristics and specifically, the median nerve volume within the tunnel, electrophysiological findings, grip strength and subjective pain evaluation (Table 1) . In both groups, the nerve volume was higher 90 days post-surgery than before the surgery (Fig. 2a) . With adjustment for the pre-surgery value, age, sex and whether the affected hand was a dominant one, the increase was somewhat higher in the test group (mean 9.9 mm 3 in the ITT and 10.5 mm 3 in the PP set, p<0.001, respectively) than in the control group (7.2 mm 3 in both ITT and PP sets, p00.002). At 180 days, the volume increased further, and the adjusted difference vs. the pre-surgery value was somewhat lower in the test (mean 13.3 and 13.7 mm 3 for ITT and PP data, respectively, p<0.001) than in the control group (mean 14.6 and 14.7 mm 3 for ITT and PP data, respectively, p<0.001). Consequently, the adjusted mean difference between the test and control treatment for the overall post-surgery period was slightly but insignificantly in favour of the test treatment (relatively, by around 5.7 % larger volume in the ITT and by around 9.4 % in the PP data set) (Fig. 2b) . The difference was the largest at 90 days when it attained borderline statistical significance in the PP data set (by around 14.5 % larger nerve volume, p00.056), whereas there was practically no difference between the treatments at 180 days post surgery (Fig. 2b) .
The proportion of patients with normal or improved DML, and less so the proportion of patients with normal/ improved DSL, was considerably higher in both groups at 90 days post-surgery than before the surgery, and further increased at 180 days post-surgery (Fig. 3a,b) . No trend of differences between the two treatments at any time post-surgery was observed. Also, when the post-surgical nerve volume was considered as a timevarying covariate, no indication of an effect on DML or DSL was observed.
In the test group, grip strength was practically identical at 90 and 180 days post-surgery vs. pre-surgery, whereas in the control group it decreased at 90 days and returned to presurgery values at 180 days post-surgery (Fig. 3c) . The decrease in the control group at 90 days was statistically significant (adjusted difference around −3.8 kg, in both ITT and PP sets, p00.006). Consequently, at 90 days post-surgery grip strength was higher in the test than in the control group with borderline statistical significance (adjusted mean difference around 3.3 kg, p00.083 in the ITT set, around 3.2 kg, p00.091 in the PP set), whereas no such trend was seen for the overall postsurgery period or at 180 days post-surgery. Also, no indication of an effect of the post-surgical nerve volume on the grip strength was observed.
The VAS score for pain greatly decreased post-surgery in both groups (Fig. 3d) . The adjusted differences in VAS pain score vs. pre-surgery were highly statistically significant (p <0.001) in both groups at both follow-up visits, in both ITT and PP data sets. However, the VAS pain score reduction was somewhat lower in the test than in the control group (e.g., in the ITT data set, around 2.5 and 2.9 points at 90 and 180 days in the test group vs. around 3.6 and around 4.7 points in the control group). Consequently, in the ITT data set, considering the overall post-surgery period, VAS score for pain was higher in the test than in the control group with borderline statistical significance (adjusted mean difference around 1.0 point, p00.056) (Fig. 4) , and it was significantly higher at 180 days post-surgery (difference around 1.38 points, p00.017) (Fig. 4) . In the PP set, the difference at 180 days was borderline significant (around 0.97 points, p0 0.090) (Fig. 4) . When the post-surgical nerve volume was considered as a time-varying covariate and with adjustment for treatment, visit, age, sex, pre-surgery VAS score and whether the affected hand was a dominant one, larger volume was associated with a lower VAS pain score in both ITT and PP data sets (Fig. 5) . In both sets, the volume/treatment interaction was statistically significant indicating different relationship between the postsurgical nerve volume and pain score in the two treatment groups; while in the test group there was no apparent association, in the control group higher volume was associated with lower pain (Fig. 5 ).
There were no complications during the study. All patients were satisfied with the functional and cosmetic outcomes.
Discussion
It has been suggested that in the CTS patients with a prominent narrowing of the median nerve longitudinal epineurotomy would obtain a greater pressure relief, better nerve volume recovery and better outcomes than a standard carpal ligament dissection [7, 8] . Several trials have failed to demonstrate clinical and electrophysiological advantages of the procedure, however they were not restricted to Fig. 4 Adjusted mean differences between the test and control treatment in visual analogue scale (VAS) score for pain. ITT (LOCF) intentto-treat patients with last observation carried forward, PP per protocol patients Fig. 5 The effect of the postsurgical median nerve volume on the post-surgical visual analogue scale (VAS) score for pain, overall and in the test and the control groups. ITT (LOCF) intent-to-treat patients with last observation carried forward, PP per protocol patients patients with a prominent nerve narrowing/fibrosis [5, 6, 10] . Our trial is the first in this specific (sub)population and the first to assess the underlying concept that in these patients the procedure allows for a better nerve volume recovery, and by doing so, better clinical outcomes. It is limited by a relatively small sample, but it was powered to detect a reasonably small difference (25 %) between the test (epineurotomy) and control (no epineurotomy) procedure regarding the nerve volume. On the other hand, randomisation and blinding have achieved a fair level of internal validity. Under these circumstances, we observed a somewhat greater nerve volume in the test than in the control group 90 days post-surgery, but not 180 days post-surgery. The difference was modest and the trial was not sufficiently powered to detect it as statistically significant. Still, as it was similar for the ITT (around 10.5 %) and PP data (around 14.5 %), it appears that epineurotomy does enable a somewhat more rapid recovery of the nerve volume than the standard procedure. However, we found no evidence to support the concept that a larger increase in the nerve volume per se should a priori be considered beneficial. Although the increase in the nerve volume parallelled the improvement in the electrophysiological outcomes, we found no indication of an independent association between the two. Consequently, and in line with the previous trials [5, 6, 10] , we found no evidence of a beneficial effect of epineurotomy on electrophysiological outcomes. It should be noted that the implemented measures were rather crude due to the fact that, as expected, motor and particularly informative. Similarly, we found no indication of an effect of a larger nerve volume on the grip strength, and no relevant difference between the two treatments in this respect. On the other hand, larger post-surgical nerve volume was independently associated with a greater self-reported pain reduction. However, the effect was apparent only with the control procedure suggesting that epineurotomy per se might modify the relationship between the nerve volume and post-surgical pain. In accordance with this finding, the reduction in the VAS pain scores appeared somewhat more pronounced in the control group resulting in somewhat higher VAS pain scores in the test group 180 days after the surgery. Although the difference attained statistical significance in the ITT data set, it was small in size (around 1.38 points) and probably without any practical relevance.
In conclusion, in line with other reports [5, 6, 10] , the results suggest that even in selected patients longitudinal epineurotomy of the median nerve does not confer any relevant electrophysiolgical or clinical benefit (nor harm), as compared to a simple dissection of the carpal ligament. Moreover, they question the concept that in these patients a benefit could/should be expected due to a more prominent effect on the nerve volume restoration. Therefore, the simple release of the carpal tunnel should be considered the surgical method of choice for the treatment of CTS [18] [19] [20] [21] [22] . sensory conductivity blocks were common in this (sub) population of patients, but should be considered practically
